semaglutide anxiety
32% Fewer Anxiety Diagnoses When Taking Semaglutide
In the latest trial, 32% fewer patients on semaglutide were diagnosed with anxiety over 12 months compared with matched controls, indicating a clear mental-health benefit alongside weight loss. The finding reshapes how clinicians view GLP-1 therapies, merging metabolic and psychiatric outcomes. Medical Disclaimer: This article is for informational purposes only